Skip to content

Evaluation of the efficacy of surgery compared to chemotherapy for pleural dissemination of thymoma

Evaluation of the efficacy of surgery compared to chemotherapy for pleural dissemination of thymoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081313
Enrollment
Unknown
Registered
2024-02-28
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thymoma

Interventions

Trail group:None

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) patients had histologically confirmed TMs; (2) patients were staged as IVA because of pleural dissemination; (3) patients received chemotherapy or surgery as first-line treatment.

Exclusion criteria

Exclusion criteria: (1) imaging data before or after treatment was unavailable; (2) patients had TCs; (3) patients received radiation as first-line treatment.

Design outcomes

Primary

MeasureTime frame
objective rseponse rate;

Secondary

MeasureTime frame
disease control time;progression free survival;overall survival;

Countries

China

Contacts

Public ContactWentao Fang

Shanghai Chest Hospital

vwtfang@hotamail.com+86 180 1732 1389

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026